A method of inhibiting bacterial sialidase comprising administering to a subject an inhibiting effective amount of a compound of formula I: [ STR 1 ] wherein A is CO.sub.2 H, PO.sub.2 H, or SO.sub.2 H; B is N; R.sub.1 and R.sub.2 are H; R.sub.3 and R.sub.4 are, independently, H, OH, NO.sub.2, guanid
A method of inhibiting bacterial sialidase comprising administering to a subject an inhibiting effective amount of a compound of formula I: [ STR 1 ] wherein A is CO.sub.2 H, PO.sub.2 H, or SO.sub.2 H; B is N; R.sub.1 and R.sub.2 are H; R.sub.3 and R.sub.4 are, independently, H, OH, NO.sub.2, guanidino, or alkyl or alkenyl of from 1 to 3 carbons where the alkyl or alkenyl is unsubstituted or is substituted, independently, with one or more of OH, NH2, or halide; R.sub.5 is H; and R.sub.6 is COCH.sub.3, or COCI.sub.3 ; or an analog, pharmaceutically acceptable salt, derivative, or mixture thereof. A method of preventing a bacterial or trypanosomal infection using the compounds of formula I. A method of treating a bacterial or trypanosomal infection using the compounds of formula I. A pharmaceutical composition comprising a pharmaceutically acceptable carrier admixed with an inhibiting effective amount of a compound of formula I. A method of making a pharmaceutical composition, comprising admixing a pharmaceutically acceptable carrier with an inhibiting effective amount of a compound of formula I.
대표청구항▼
[ What is claimed is:] [1.] A method of inhibiting bacterial sialidase comprising administering to a subject an inhibiting effective amount of a compound of formula I: [ STR 23 ] wherein A is CO.sub.2 H, PO.sub.2 H, or SO.sub.2 H; B is N; R.sub.1 and R.sub.2 are H; R.sub.3 and R.sub.4 are, independe
[ What is claimed is:] [1.] A method of inhibiting bacterial sialidase comprising administering to a subject an inhibiting effective amount of a compound of formula I: [ STR 23 ] wherein A is CO.sub.2 H, PO.sub.2 H, or SO.sub.2 H; B is N; R.sub.1 and R.sub.2 are H; R.sub.3 and R.sub.4 are, independently, H, OH, NO.sub.2, guanidino, or alkyl or alkenyl of from 1 to 3 carbons where the alkyl or alkenyl is unsubstituted or is substituted, independently, with one or more of OH, NH2, or halide; R.sub.5 is H; and R.sub.6 is COCH.sub.3, or COCI.sub.3 ; or an analog, pharmaceutically acceptable salt, derivative, or mixture thereof.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (8)
Kompis Ivan (Oberwil CHX) Rey-Bellet Grald (Basel CHX) Zanetti Guido (Fllinsdorf CHX), 2,4-Diamino-5-(4-amino and 4-dimethylamino-3,5-dimethoxy benzyl)pyrimidines.
von Izstein Laurence M. (North Fitzray AUX) Wu Wen-Yang (Mount Waverley AUX) Phan Tho V. (Carnegie AUX) Danylec Basil (Box Hill AUX) Jin Betty (Mount Waverley AUX), Derivatives and analogues of 2-deoxy-2,3-didehydro-N-acetyl neuraminic acid and their use as antiviral agents.
Luo Ming (Birmingham AL) Brouillette Wayne J. (Birmingham AL) Air Gillian (Birmingham AL), Inhibitors of influenza virus neuraminidase and methods of making and using the same.
De Simone Claudio (Rome ITX), Pharmaceutical composition comprising zidovudine and inosiplex or components thereof for the treatment of aids-related s.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.